67 
1 surveillance plans and records should be filed. Such 
2 a clearinghouse, containing records of all recombinant 
3 organises, accident reports, and nedical records, would 
4 be invaluable in ascertaining biohazard risks frou 
5 recombinant research, and establishing safety records 
6 of particular laboratories and containnent methods. 
7 Detailed energency cleanup plans should be 
8 drawn up oy the biohazards officer and the institutional 
9 biohazard committee for each recombinant DNA project. 
10 Such plans should be subnitted to the NIU for approval 
11 along with the grant application, and be stored in the 
12 central clearinghouse. 
13 In the event of any release of recombinant 
14 organisms or of noncompliance with the guidelines, the 
15 state or local health authorities should be immediately 
16 notified. The effects of any accident will be first 
17 experienced within tne local surroundings. Consequently, 
18 the state health department or its local equivalent should 
19 be informed at all times of what organisms are being used, 
20 and of all releases of recombinant organisms, even those 
21 considered minor. 
22 In summary, the Uew York State Attorney General's 
23 Office believes that there is insufficient scientific 
24 justification for the relaxation of containnent levels 
25 contained in the proposed revised guidelines. On the 
[159] 
